Regardless of what’s taking place on the earth, whether or not geopolitical battle, a cyclical downturn or the unwinding of an overleveraged hedge fund, a disciplined funding course of stays the perfect software for making constant selections with optimistic anticipated returns.
Two of essentially the most sturdy indicators accessible to buyers are earnings estimate revisions and value momentum. Shares with rising earnings expectations are likely to outperform, whereas robust relative value motion typically signifies that institutional demand is already constructing. When these indicators align, the chances of figuring out a sustained winner can enhance significantly.
Lenovo Group (LNVGY), Victoria’s Secret (VSXY) and Liquidia Company (LQDA) presently stand out on each fronts. Every carries a high Zacks Rank, advantages from optimistic earnings momentum and is displaying constructive value motion. Their charts are additionally forming bullish consolidation patterns, inserting all three close to potential breakout ranges and creating compelling alternatives for momentum-oriented buyers.
Picture Supply: Zacks Funding Analysis
Lenovo Group Inventory Surges Amid AI Momentum
Lenovo Group is greatest generally known as the world’s largest PC producer, however the firm is steadily growing right into a broader AI {hardware} and infrastructure supplier. Its Hybrid AI technique stretches from AI-enabled PCs, smartphones and workstations to enterprise servers, storage, edge computing and managed providers, giving Lenovo publicity to AI adoption throughout each private units and company knowledge facilities.
That transformation is already displaying up within the firm’s outcomes. Lenovo completed fiscal 2025/26 with report income of $83.1 billion, up 20% 12 months over 12 months. AI-related income greater than doubled and accounted for 33% of complete gross sales in the course of the 12 months. Momentum accelerated additional within the fiscal fourth quarter, when income climbed 27%, adjusted web earnings doubled and AI-related income surged 84% to symbolize 38% of the corporate’s complete.
The Infrastructure Options Group has emerged as an particularly vital progress engine. Quarterly income elevated 37% to a report $5.6 billion, whereas the phase produced its highest working revenue and margin since Lenovo entered the enterprise. The corporate additionally ended the interval with a $21 billion AI-server pipeline and greater than 5,800 buyer AI deployments. On the similar time, Lenovo retained its main place within the world PC market, the place an approaching improve cycle and the rollout of AI-enabled units present one other potential supply of progress.
Analysts have responded by sharply elevating their earnings expectations. The Zacks Consensus Estimate for the present 12 months has climbed 43% over the previous 60 days, whereas the estimate for subsequent 12 months has elevated 40%. That highly effective revision momentum offers LNVGY a Zacks Rank #1 (Robust Purchase).
Even after the inventory’s advance, the valuation doesn’t seem extreme relative to the bettering progress outlook. Shares commerce at roughly 17x ahead earnings, with gross sales anticipated to rise 17.8% this 12 months and one other 15% subsequent 12 months. That mixture of double-digit progress, quickly rising earnings estimates and increasing publicity to AI infrastructure creates a reputable case for additional a number of enlargement.
The inventory has been on a tear over the previous three months, however spent a lot of the final two months consolidating these good points in a constructive bullish sample. Shares lastly broke above that vary this week, suggesting the subsequent leg of the advance could also be underway. With estimate revisions, elementary progress and value momentum all transferring in the identical course, Lenovo seems to be present process a broader rerating from a mature PC producer right into a diversified AI {hardware} and infrastructure firm.
Picture Supply: TradingView
Shares of Victoria’s Secret Stage Turnaround
Victoria’s Secret is a number one specialty retailer of intimate attire and wonder merchandise by its Victoria’s Secret, PINK and Magnificence manufacturers. After a number of years of inconsistent efficiency and weakening model relevance, the corporate is starting to indicate significant indicators of a elementary turnaround.
Beneath CEO Hillary Tremendous, Victoria’s Secret has refocused on its core identification whereas bettering its merchandise, advertising and marketing and promotional self-discipline. The corporate is leaning again into the model’s conventional positioning, however with a extra fashionable and inclusive method, whereas additionally investing in product innovation and rebuilding momentum throughout Victoria’s Secret, PINK and Magnificence. The latest ticker change from VSCO to VSXY additional displays that renewed emphasis on the corporate’s identification.
These efforts at the moment are translating into a lot stronger monetary outcomes. First quarter web gross sales elevated 15% 12 months over 12 months to $1.56 billion, supported by 13% comparable gross sales progress. Adjusted earnings reached $0.60 per share, roughly double expectations, whereas gross margin expanded to 37.6%. Administration subsequently raised its full-year outlook, growing projected gross sales to between $7.03 billion and $7.13 billion and adjusted working earnings to between $550 million and $580 million.
Analysts have responded by elevating their earnings forecasts. The consensus estimate for the present quarter has climbed 20.3%, whereas the estimate for subsequent quarter has flipped from a lack of $0.11 per share to a revenue of $0.03. Full 12 months estimates have additionally moved increased, rising 6.9% for the present 12 months and 4.9% for subsequent 12 months. That bettering earnings outlook helps the inventory’s Zacks Rank #1 (Robust Purchase) and suggests the turnaround is gaining credibility on Wall Road.
Shares have responded with highly effective value momentum, surging alongside the bettering fundamentals earlier than consolidating right into a bullish wedge over the previous a number of weeks. Traders ought to now look ahead to a decisive breakout above the latest highs close to $91. A transfer by that stage might sign that the consolidation is full and open the door to a different leg increased.
Picture Supply: TradingView
Liquidia Company Leads the Biotech Inventory Rally
Liquidia Company is a commercial-stage biopharmaceutical firm targeted on therapies for uncommon cardiopulmonary illnesses. Its major progress driver is YUTREPIA, an FDA-approved, dry-powder formulation of treprostinil used to deal with pulmonary arterial hypertension and pulmonary hypertension related to interstitial lung illness. The drug is run by a compact, low-resistance inhaler developed utilizing Liquidia’s proprietary PRINT manufacturing know-how.
YUTREPIA’s industrial launch has been nothing wanting explosive. First-quarter web product gross sales reached roughly $130 million, lifting complete income to $132.9 million and practically matching the $148 million Liquidia generated throughout all of 2025. Greater than 4,500 distinctive prescriptions had been written and roughly 3,750 sufferers had begun therapy by the tip of April. That fast adoption helped Liquidia produce its third consecutive worthwhile quarter, with web earnings of $52.9 million and adjusted EBITDA of $71.2 million.
With gross sales projected to climb roughly 316% this 12 months and one other 67% subsequent 12 months, analysts have struggled to maintain tempo with the pace of Liquidia’s industrial ramp. Earnings estimates have trended sharply increased over the previous 12 months, reflecting stronger-than-expected demand and the corporate’s fast transition from a development-stage biotech right into a worthwhile industrial enterprise. That highly effective revision momentum offers LQDA a Zacks Rank #1 (Robust Purchase).
The inventory’s value motion has adopted the bettering fundamentals. LQDA shares have repeatedly consolidated and damaged out over the previous 18 months as buyers have adjusted to the corporate’s quickly increasing gross sales and earnings outlook. After one other orderly pause, shares have now damaged above a tidy bull flag, suggesting the longer-term advance could also be able to resume.
Biotechnology shares typically rally on expectations properly earlier than significant income arrives. Liquidia stands out as a result of its breakout is being supported by actual product demand, accelerating gross sales and quickly increasing profitability. With Wall Road estimates persevering with to maneuver increased, LQDA stays one of many strongest progress and momentum tales within the biotech sector.
Picture Supply: TradingView
Ought to Traders Purchase Shares of LQDA, VSXY and LNVGY?
LNVGY, VSXY and LQDA every mix a Zacks Rank #1 (Robust Purchase) with rising earnings estimates and constructive technical setups. Though the three firms function in very completely different industries, all are benefiting from bettering fundamentals that seem to help their latest value energy.
Traders ought to nonetheless account for his or her distinct dangers, together with Lenovo’s cyclical {hardware} publicity, the execution calls for of Victoria’s Secret’s turnaround and Liquidia’s dependence on a comparatively concentrated product portfolio. Even so, the alignment of earnings momentum and value momentum makes all three compelling candidates for buyers searching for shares able to extending their present breakouts.
Analysis Chief Names “Single Greatest Choose to Double”
From 1000’s of shares, 5 Zacks specialists every have chosen their favourite to skyrocket +100% or extra in months to come back. From these 5, Director of Analysis Sheraz Mian hand-picks one to have essentially the most explosive upside of all.
This firm targets millennial and Gen Z audiences, producing practically $1 billion in income final quarter alone. A latest pullback makes now an excellent time to leap aboard. In fact, all our elite picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Nano-X Imaging which shot up +129.6% in little greater than 9 months.
Free: See Our Prime Inventory And 4 Runners Up
Lenovo Group Ltd. (LNVGY) : Free Inventory Evaluation Report
Liquidia Company (LQDA) : Free Inventory Evaluation Report
Victoria’s Secret & Co. (VSXY) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
